{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T03:09:21Z","timestamp":1768532961321,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.toxicon.2019.10.006","type":"journal-article","created":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T20:08:09Z","timestamp":1571083689000},"page":"78-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Development of a human scFv antibody targeting the lethal Iranian cobra (Naja oxiana) snake venom"],"prefix":"10.1016","volume":"171","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5832-1822","authenticated-orcid":false,"given":"Fatemeh","family":"Kazemi-Lomedasht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montarop","family":"Yamabhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marc","family":"Sabatier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Behdani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Zareinejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delavar","family":"Shahbazzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2019.10.006_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/980250","article-title":"scFv antibody: principles and clinical application","volume":"2012","author":"Ahmad","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.toxicon.2019.10.006_bib2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0041-0101(96)00181-X","article-title":"Time factor in the detection of circulating whole venom and crotoxin and efficacy of antivenom therapy in patients envenomed by Crotalus durissus","volume":"35","author":"Amaral","year":"1997","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2019.10.006_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141045","article-title":"A novel human scFv library with non-combinatorial synthetic CDR diversity","volume":"10","author":"Bai","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.toxicon.2019.10.006_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/antib8020028","article-title":"David vs. Goliath: the structure, function, and clinical prospects of antibody fragments","volume":"8","author":"Bates","year":"2019","journal-title":"Antibodies"},{"key":"10.1016\/j.toxicon.2019.10.006_bib5","first-page":"11","article-title":"Snake venoms and antivenoms: critical supply issues","volume":"52","author":"Bawaskar","year":"2004","journal-title":"J. Assoc. Phys. India"},{"key":"10.1016\/j.toxicon.2019.10.006_bib6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0022-1759(87)90187-6","article-title":"Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay","volume":"100","author":"Beatty","year":"1987","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.toxicon.2019.10.006_bib7","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3390\/toxins6051526","article-title":"Ophiophagus hannah venom: proteome, components bound by Naja kaouthia antivenin and neutralization by N. kaouthia neurotoxin-specific human ScFv","volume":"6","author":"Danpaiboon","year":"2014","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2019.10.006_bib8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.toxicon.2014.08.063","article-title":"Ten years of snakebites in Iran","volume":"90","author":"Dehghani","year":"2014","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2019.10.006_bib9","series-title":"The Complete Fauna of Iran","author":"Firouz","year":"2005"},{"key":"10.1016\/j.toxicon.2019.10.006_bib10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMra013477","article-title":"Bites of venomous snakes","volume":"347","author":"Gold","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.toxicon.2019.10.006_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0014-5793(73)80340-0","article-title":"Amino acid sequence of neurotoxin II from Naja naja oxiana venom","volume":"36","author":"Grishin","year":"1973","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxicon.2019.10.006_bib12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0014-5793(74)80825-2","article-title":"Amino acid sequence of neurotoxin I from Naja naja oxiana venom","volume":"45","author":"Grishin","year":"1974","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxicon.2019.10.006_bib13","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.2174\/1381612822666160623073438","article-title":"From fangs to pharmacology: the future of snakebite envenoming therapy","volume":"22","author":"H Laustsen","year":"2016","journal-title":"Curr. Pharmaceut. Des."},{"issue":"7","key":"10.1016\/j.toxicon.2019.10.006_bib51","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1021\/es60130a004","article-title":"Trimmed Spearman-Karber method for estimating median lethal concentrations in toxicity bioassays","volume":"11","author":"Hamilton","year":"1977","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.toxicon.2019.10.006_bib14","first-page":"1201","article-title":"Preparation and characterization of a novel nanobody against T-cell immunoglobulin and mucin-3 (TIM-3)","volume":"19","author":"Homayouni","year":"2016","journal-title":"Iranian J. Basic Med. Sci."},{"key":"10.1016\/j.toxicon.2019.10.006_bib15","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.1073\/pnas.85.16.5879","article-title":"Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli","volume":"85","author":"Huston","year":"1988","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.toxicon.2019.10.006_bib16","series-title":"Antibodies to Watch in 2019, MAbs","first-page":"219","author":"Kaplon","year":"2019"},{"key":"10.1016\/j.toxicon.2019.10.006_bib17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.molimm.2015.01.010","article-title":"Inhibition of angiogenesis in human endothelial cell using VEGF specific nanobody","volume":"65","author":"Kazemi-Lomedasht","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.toxicon.2019.10.006_bib18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/mab.2016.0001","article-title":"Production and characterization of novel camel single domain antibody targeting mouse vascular endothelial growth factor","volume":"35","author":"Kazemi-Lomedasht","year":"2016","journal-title":"Monoclon. Antibodies Immunodiagn. Immunother."},{"key":"10.1016\/j.toxicon.2019.10.006_bib19","first-page":"201","article-title":"Selection and characterization of specific Nanobody against human immunoglobulin G","volume":"vol. 34","author":"Kazemi-Lomedasht","year":"2015"},{"key":"10.1016\/j.toxicon.2019.10.006_bib20","series-title":"Anti-tumor Activity of Iranian Cobra Snake (Naja Oxiana) Venom on Lung Cancer Cell Line","author":"Kazemi-Lomedasht","year":"2019"},{"key":"10.1016\/j.toxicon.2019.10.006_bib21","first-page":"489","article-title":"In vivo immunotherapy of lung cancer using cross-species reactive vascular endothelial growth factor nanobodies","volume":"20","author":"Kazemi-Lomedasht","year":"2017","journal-title":"Iranian J. Basic Med. Sci."},{"key":"10.1016\/j.toxicon.2019.10.006_bib22","first-page":"1","article-title":"Linear mimotope analysis of Iranian cobra (Naja oxiana) snake venom using peptide displayed phage library","author":"Kazemi-Lomedasht","year":"2018","journal-title":"Toxin Rev."},{"key":"10.1016\/j.toxicon.2019.10.006_bib23","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.4161\/hv.28531","article-title":"Study on camel IgG purification: a new approach to prepare Naja Naja Oxiana antivenom as passive immunization for therapy","volume":"10","author":"Khamehchian","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.toxicon.2019.10.006_bib24","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jprot.2008.12.007","article-title":"Human monoclonal ScFv neutralize lethal Thai cobra, Naja kaouthia, neurotoxin","volume":"72","author":"Kulkeaw","year":"2009","journal-title":"J. Proteomics"},{"key":"10.1016\/j.toxicon.2019.10.006_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.toxicon.2018.03.004","article-title":"Pros and cons of different therapeutic antibody formats for recombinant antivenom development","volume":"146","author":"Laustsen","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2019.10.006_bib26","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1038\/s41467-018-06086-4","article-title":"In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies","volume":"9","author":"Laustsen","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.toxicon.2019.10.006_bib27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.toxicon.2015.07.334","article-title":"Selecting key toxins for focused development of elapid snake antivenoms and inhibitors guided by a Toxicity Score","volume":"104","author":"Laustsen","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2019.10.006_bib28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/protein\/gzv024","article-title":"A fully human scFv phage display library for rapid antibody fragment reformatting","volume":"28","author":"Li","year":"2015","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.toxicon.2019.10.006_bib29","first-page":"399","article-title":"Anti-snake venom properties of medicinal plants","volume":"2","author":"Makhija","year":"2010","journal-title":"Der Pharm. Lett."},{"key":"10.1016\/j.toxicon.2019.10.006_bib30","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.biocel.2013.06.009","article-title":"Applications of snake venom components to modulate integrin activities in cell\u2013matrix interactions","volume":"45","author":"Marcinkiewicz","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.toxicon.2019.10.006_bib31","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/348552a0","article-title":"Phage antibodies: filamentous phage displaying antibody variable domains","volume":"348","author":"McCafferty","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.toxicon.2019.10.006_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxicon.2004.07.028","article-title":"Molecular diversity and accelerated evolution of C-type lectin-like proteins from snake venom","volume":"45","author":"Ogawa","year":"2005","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2019.10.006_bib33","series-title":"Cytotoxicity, Anti-adhesive and Anti-angiogenic Effects of Caspian Cobra Snake (Naja Oxiana) Venom on Human Endothelial Cells","author":"Oghalaie","year":"2017"},{"key":"10.1016\/j.toxicon.2019.10.006_bib34","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.bbrc.2004.08.131","article-title":"Optimal construction of non-immune scFv phage display libraries from mouse bone marrow and spleen established to select specific scFvs efficiently binding to antigen","volume":"323","author":"Okamoto","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.toxicon.2019.10.006_bib35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF03027399","article-title":"Current status of cancer therapy with radiolabeled monoclonal antibody","volume":"19","author":"Oriuchi","year":"2005","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.toxicon.2019.10.006_bib36","series-title":"Venomous Animal Injuries. Emergency Medicine Concepts and Clinical Practices","first-page":"924","author":"Otten","year":"1998"},{"key":"10.1016\/j.toxicon.2019.10.006_bib37","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1472-6750-9-6","article-title":"A compact phage display human scFv library for selection of antibodies to a wide variety of antigens","volume":"9","author":"Pansri","year":"2009","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.toxicon.2019.10.006_bib38","series-title":"An in Silico Study to Find Angiogenesis Inhibitory Role for Naja Oxiana Snake Venom Cytotoxins","author":"Pourhashem","year":"2018"},{"key":"10.1016\/j.toxicon.2019.10.006_bib39","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.3389\/fimmu.2019.02090","article-title":"Bee updated: current knowledge on bee venom and bee envenoming therapy","volume":"10","author":"Pucca","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.toxicon.2019.10.006_bib40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/1547691X.2013.809175","article-title":"Serrumab: a novel human single chain-fragment antibody with multiple scorpion toxin-neutralizing capacities","volume":"11","author":"Pucca","year":"2014","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.toxicon.2019.10.006_bib41","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.apjtb.2017.06.001","article-title":"An overview on application of phage display technique in immunological studies","volume":"7","author":"Rami","year":"2017","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"10.1016\/j.toxicon.2019.10.006_bib42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1023\/A:1017972511272","article-title":"Variation in biochemical and pharmacological properties of Indian cobra (Naja naja naja) venom due to geographical distribution","volume":"229","author":"Shashidharamurthy","year":"2002","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.toxicon.2019.10.006_bib43","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.actatropica.2017.09.001","article-title":"Discovery of human scFvs that cross-neutralize the toxic effects of B. jararacussu and C. d. terrificus venoms","volume":"177","author":"Silva","year":"2018","journal-title":"Acta Trop."},{"key":"10.1016\/j.toxicon.2019.10.006_bib44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4314\/tjpr.v17i3.4","article-title":"Optimization of purification procedure for horse F (ab) 2 antivenom against Androctonus crassicauda (Scorpion) venom","volume":"17","author":"Taherian","year":"2018","journal-title":"Trop. J. Pharm. Res."},{"key":"10.1016\/j.toxicon.2019.10.006_bib45","first-page":"497","article-title":"Epidemiological study of patients with snake biting in the hospitals of Ahvaz, Iran","volume":"11","author":"Vazirianzadeh","year":"2008","journal-title":"J. Exp. Zool. India"},{"key":"10.1016\/j.toxicon.2019.10.006_bib46","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/nbt.4305","article-title":"Biopharmaceutical benchmarks 2018","volume":"36","author":"Walsh","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.toxicon.2019.10.006_bib47","first-page":"3845s","article-title":"Selection and characterization of anti-MUC-1 scFvs intended for targeted therapy","volume":"9","author":"Winthrop","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.toxicon.2019.10.006_bib48","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.4269\/ajtmh.15-0871","article-title":"Venom and purified toxins of the spectacled cobra (Naja naja) from Pakistan: insights into toxicity and antivenom neutralization","volume":"94","author":"Wong","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.toxicon.2019.10.006_bib49","first-page":"3402","article-title":"Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms","volume":"52","author":"Yokota","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.toxicon.2019.10.006_bib50","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3109\/07388551.2014.958978","article-title":"Phage antibody display libraries: a powerful antibody discovery platform for immunotherapy","volume":"36","author":"Zhao","year":"2016","journal-title":"Crit. Rev. Biotechnol."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010119304866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010119304866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:13:12Z","timestamp":1758575592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010119304866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":51,"alternative-id":["S0041010119304866"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2019.10.006","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a human scFv antibody targeting the lethal Iranian cobra (Naja oxiana) snake venom","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2019.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}